Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  The Lancet Oncology

• Publication date

  2005-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1470-2045(05)70282-5PMID 16054571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of collagen type I, II, X and Ki-67 in osteochondroma compared to human growth plate cartilage.

  2010cited by this paper
• Dysregulation of hedgehog signalling predisposes to synovial chondromatosis

  2005cited by this paper
• Cryosurgery in aggressive, benign, and low-grade malignant bone tumours.

  2005cited by this paper
• The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting

  2005cited by this paper
• Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas

  2005cited by this paper
• cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade

  2005cited by this paper
• World Health Organisation classification of tumours: pathology and genetics of tumours of soft tissue and bone: Edited by C. D. M. Fletcher K. K. Unni and F. Mertens Pp. 427, Lyon, France: IARC Press, 2002, ISBN: 9-2832-2413-2, £53.00

  2004cited by this paper
• Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C

  2004cited by this paper
• Cyclooxygenase-2 Expression in Chondrosarcoma

  2004cited by this paper
• Molecular analysis of the INK4A/INK4A‐ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression

  2004cited by this paper
• Therapeutic potential of antisense Bcl‐2 as a chemosensitizer for cancer therapy

  2004cited by this paper
• Clear-cell chondrosarcoma

  2004cited by this paper
• Multiple Osteochondromas: Clinicopathological and Genetic Spectrum and Suggestions for Clinical Management

  2004cited by this paper
• Evaluation of HER-2/neu status by real-time quantitative PCR in malignant cartilaginous tumors.

  2004cited by this paper
• Genetics of chondrosarcoma and related tumors

  2004cited by this paper
• Nature Encyclopaedia of the Human Genome

  2004cited by this paper
• Inhibition of MMP‐1 expression by antisense RNA decreases invasiveness of human chondrosarcoma

  2003cited by this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasms.

  2003cited by this paper
• Genetic and epigenetic alterations in tumor progression in a dedifferentiated chondrosarcoma.

  2003cited by this paper
• Antiangiogenesis treatment combined with chemotherapy produces chondrosarcoma necrosis.

  2003cited by this paper
• Monoclonal antibody to parathyroid hormone-related protein induces differentiation and apoptosis of chondrosarcoma cells.

  2003cited by this paper
• Mesenchymal chondrosarcoma: molecular characterization by a proteomic approach, with morphogenic and therapeutic implications.

  2003cited by this paper
• Fusion, Disruption, and Expression of HMGA2 in Bone and Soft Tissue Chondromas

  2003cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma.

  2002cited by this paper
• A mutant PTH/PTHrP type I receptor in enchondromatosis

  2002cited by this paper
• CO‐EXPRESSION OF PARATHYROID HORMONE‐RELATED PROTEIN (PTHRP) AND PTH/PTHRP RECEPTOR IN CARTILAGINOUS TUMOURS: A MARKER FOR MALIGNANCY?

  2002cited by this paper
• Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group

  2002cited by this paper
• Parathyroid Hormone-Related Peptide Expression in Cartilaginous Tumors

  2002cited by this paper
• Translocation der(13;21)(q10;q10) in Skeletal and Extraskeletal Mesenchymal Chondrosarcoma

  2002cited by this paper
• Recurring breakpoints of 1p13 approximately p22 in osteochondroma.

  2002cited by this paper
• World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone

  2002cited by this paper
• Diagnosis and prognosis of chondrosarcoma of bone

  2002cited by this paper
• Enchondromatosis: Ollier disease and Maffucci syndrome

  2002cited by this paper
• Recurring breakpoints of 1p13∼p22 in osteochondroma

  2002cited by this paper
• Towards a new understanding and classification of chondrogenic neoplasias of the skeleton – biochemistry and cell biology of chondrosarcoma and its variants

  2002cited by this paper
• Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.

  2001cited by this paper
• Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes.

  2001cited by this paper
• Platelet-Derived Growth Factor-&agr; Receptor Expression Supports the Growth of Conventional Chondrosarcoma and Is Associated With Adverse Outcome

  2001cited by this paper
• Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma.

  2001cited by this paper
• H-ras Oncogene Mutation in Dedifferentiated Chondrosarcoma: Polymerase Chain Reaction-Restriction Fragment Length Polymorphism Analysis

  2001cited by this paper
• Low incidence of genetic alterations of the p16CDKN2a in clear cell chondrosarcoma.

  2001cited by this paper
• High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma.

  2001cited by this paper
• Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma

  2000cited by this paper
• Multidrug resistance-1 and p-glycoprotein in human chondrosarcoma cell lines: expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance.

  2000cited by this paper
• Cartilaginous tumors: fast contrast-enhanced MR imaging.

  2000cited by this paper
• Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.

  2000cited by this paper
• Changes of the p16 gene but not the p53 gene in human chondrosarcoma tissues

  2000cited by this paper
• Microvasculature and VEGF expression in cartilaginous tumors.

  2000cited by this paper
• Up-Regulation of PTHrP and Bcl-2 Expression Characterizes the Progression of Osteochondroma towards Peripheral Chondrosarcoma and Is a Late Event in Central Chondrosarcoma

  2000cited by this paper
• Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma.

  2000cited by this paper
• Expression of Indian Hedgehog, Parathyroid Hormone‐Related Protein, and Their Receptors in the Postnatal Growth Plate of the Rat: Evidence for a Locally Acting Growth Restraining Feedback Loop After Birth

  2000cited by this paper
• Multidrug resistance‐1 and p‐glycoprotein in human chondrosarcoma cell lines: Expression correlates with decreased intracellular doxorubicin and in vitro chemoresistance

  1999cited by this paper
• Clear cell chondrosarcoma: a pathological and immunohistochemical study

  1999cited by this paper
• Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. II. Juxtacortical cartilage tumors

  1999cited by this paper
• Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma

  1999cited by this paper
• Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis

  1999cited by this paper
• EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas.

  1999cited by this paper
• Chondrosarcoma of the phalanx

  1999cited by this paper
• Primary synovial chondromatosis: a clinicopathologic review and assessment of malignant potential.

  1998cited by this paper
• Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11‐12 (EXT2) in patients with sporadic and hereditary osteochondromas

  1998cited by this paper
• Chemotherapy and P‐glycoprotein expression in chondrosarcoma

  1998cited by this paper
• PTHrP and Bcl-2: essential regulatory molecules in chondrocyte differentiation and chondrogenic tumors.

  1998cited by this paper
• Primary chondrosarcoma of long bones and limb girdles

  1998cited by this paper
• P‐glycoprotein expression in cartilaginous tumors

  1997cited by this paper
• Hereditary multiple exostoses (EXT): mutational studies of familial EXT1 cases and EXT-associated malignancies.

  1997cited by this paper
• Gains, losses, and amplifications of DNA sequences evaluated by comparative genomic hybridization in chondrosarcomas.

  1997cited by this paper
• Usefulness of radiography in differentiating enchondroma from central grade 1 chondrosarcoma.

  1997cited by this paper
• Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology. I. The intramedullary cartilage tumors.

  1997cited by this paper
• Benign and malignant cartilage tumors of bone and joint: their anatomic and theoretical basis with an emphasis on radiology, pathology and clinical biology

  1997cited by this paper
• Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma

  1997cited by this paper
• Dahlin's Bone Tumors: General Aspects and Data on 11,087 Cases

  1996cited by this paper
• The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes

  1996cited by this paper
• Positional cloning of a gene involved in hereditary multiple exostoses.

  1996cited by this paper
• Chromosome rearrangements in synovial chondromatous lesions.

  1996cited by this paper
• Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1)

  1995cited by this paper
• p53 expression and DNA ploidy of cartilage lesions.

  1995cited by this paper
• Loss of chromosome band 8q24 in sporadic osteocartilaginous exostoses

  1994cited by this paper
• Radiologic Atlas of Bone Tumors

  1993cited by this paper
• Immunohistochemical detection of the c‐erbB‐2 proto‐oncogene product in normal, benign and malignant cartilage tissues

  1989cited by this paper
• Dahlin's bone tumors :

  1986cited by this paper
• A new histologic approach to the differentiation of enchondroma and chondrosarcoma of the bones. A clinicopathologic analysis of 51 cases.

  1985cited by this paper
• Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading

  1977cited by this paper
• Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases.

  1972cited by this paper

• Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial.

  2026cites this paper
• Establishment and characterization of NCC-dCS2-C1: a novel patient-derived cell line of dedifferentiated chondrosarcoma

  2025cites this paper
• Pediatric Osteosarcoma and Chondrosarcoma: Recent Advances and Future Directions in Diagnosis and Treatment

  2025cites this paper
• Chondrosarcoma in Japan: an analytic study using population-based National Cancer Registry.

  2025cites this paper
• Andrographolide suppresses chondrosarcoma cell migration and invasion by inhibiting the PI3K/Akt/mTOR signaling pathway and activating autophagy

  2025cites this paper
• Research trends and foci in chondrosarcoma: A bibliometric and network analysis

  2024cites this paper
• Novel machine‐learning prediction tools for overall survival of patients with chondrosarcoma: Based on recursive partitioning analysis

  2024cites this paper
• Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo.

  2024cites this paper
• Combined Application of Cold Physical Plasma and Chemotherapeutics against Chondrosarcoma Cells

  2024cites this paper
• LINC00665 aggravates the malignant phenotypes in chondrosarcoma cells through miR-665/FGF9 pathway.

  2024cites this paper
• Chondrosarcoma of Great Toe: A Case Report

  2023cites this paper
• Classification of Chondrosarcoma: From Characteristic to Challenging Imaging Findings

  2023cites this paper
• Construction of novel predictive tools for post-surgical cancer-specific survival probability in patients with primary chondrosarcoma and external validation in Chinese cohorts: a large population-based retrospective study

  2023cites this paper
• Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer

  2022cites this paper
• Application of additively manufactured 3D scaffolds for bone cancer treatment: a review

  2022cites this paper
• The role of mesenchymal stem cells in bone cancer

  2022cites this paper
• Benign and low-grade cartilaginous tumors: an update on differential diagnosis

  2022cites this paper
• Outcomes and Complications of Pelvic Chondrosarcomas Treated Using Navigation Guidance and Multidisciplinary Approach: Is the Tumor Volume a Prognostic Factor?

  2022cites this paper
• SOX9 and SATB2 Immunohistochemistry Cannot Reliably Distinguish Between Osteosarcoma and Chondrosarcoma on Biopsy Material.

  2022cites this paper
• Establishment and validation of an individualized nomogram to predict distant metastasis in chondrosarcoma patients: a population-based study

  2021cites this paper
• Immunohistochemical expression of sonic hedgehog signaling and its influence on angiogenesis in osteosarcoma and chondrosarcoma

  2021cites this paper
• Growth Inhibition and Induction of Innate Immune Signaling of Chondrosarcomas with Epigenetic Inhibitors

  2021cites this paper
• Chondrosarcoma of the Pelvis

  2021cites this paper
• Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade

  2021cites this paper
• Effect of Cryoablation Treatment on the Protein Expression Profile of Low-Grade Central Chondrosarcoma Identified by LC-ESI-MS/MS.

  2021cites this paper
• Metabolic Pathways and Targets in Chondrosarcoma

  2021influential citation
• Prognostic Nomograms to Predict Overall Survival and Cancer-specific Survival in Sacrum/Pelvic Chondrosarcoma (SC) Patients: A Population-based Propensity Score-matched Study.

  2020cites this paper
• Heterogeneity of chondrosarcomas response to irradiations with X-rays and carbon ions: A comparative study on five cell lines

  2020cites this paper
• Knorpeltumoren: Morphologie, Genetik und Basisaspekte der Targettherapie

  2020cites this paper
• Diagnosis of Musculoskeletal Tumors and Tumor-like Conditions: Clinical, Radiological and Histological Correlations - The Rizzoli Case Archive

  2020cites this paper
• Chondrosarcoma

  2020cites this paper
• Tumors and Tumor-Like Lesions of Bone

  2020influential citation
• Chest Wall Tumors

  2020cites this paper
• Maligne beentumoren

  2020cites this paper
• CMAR_A_253201 3513..3525

  2020cites this paper
• A system-level approach identifies HIF-2α as a critical regulator of chondrosarcoma progression

  2020cites this paper
• Cervical Spine Chondrosarcoma in an Adult with a History of Wilms Tumor: A Case Report.

  2020cites this paper
• Chondrosarcoma of the Ribs

  2020cites this paper
• Apatinib for Treatment of Inoperable Metastatic or Locally Advanced Chondrosarcoma: What We Can Learn About the Biological Behavior of Chondrosarcoma from a Two-Center Study

  2020cites this paper
• Open resection and reconstruction of a Nasoseptal Chondrosarcoma: case report and literature review

  2020cites this paper
• Technical advances in x-ray microbeam radiation therapy

  2019cites this paper
• Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery

  2019cites this paper
• Hypoxia-inducible factor 1-alpha and vascular endothelial growth factor in cartilage tumors

  2019cites this paper
• Has the Scottish Managed Clinical Network for Sarcoma influenced the survival outcomes for primary malignant bone tumours?

  2019influential citation
• Female gender in the hormonally active age group plays a major role in high-grade chondrosarcoma survival

  2019cites this paper
• Grade 2 Chondrosarcoma of the Great Toe: An Unusual Location.

  2019cites this paper
• Prognostic Factors and Treatment Options for Patients with High-Grade Chondrosarcoma

  2019cites this paper
• mir-21-5p inhibits the progression of human chondrosarcoma by regulating CCR7/STAT3/NF-κB pathway

  2019cites this paper
• BET bromodomains' functions in bone-related pathologies.

  2019cites this paper
• Understanding the Role of IDH Mutation in Chondrosarcoma

  2019cites this paper
• Biology of Conventional Chondrosarcoma

  2019cites this paper
• Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the Surveillance, Epidemiology, and End Results database

  2019cites this paper
• Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.

  2019cites this paper
• Constitutive activation of EGFR is associated with tumor progression and plays a prominent role in malignant phenotype of chondrosarcoma

  2019cites this paper
• Bone sarcomas: ESMO–ERN PaedCan–EURACAN: Clinical Practice Guidelines for diagnosis, treatment and follow-up

  2019cites this paper
• New Chondrosarcoma Cell Lines with Preserved Stem Cell Properties to Study the Genomic Drift During In Vitro/In Vivo Growth

  2019cites this paper
• An Unusual Cervical Mass in the Hyoid Bone: Intermediate-Grade Chondrosarcoma

  2019cites this paper
• Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis

  2019cites this paper
• Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery

  2018cites this paper
• Apigenin inhibits proliferation of human chondrosarcoma cells via cell cycle arrest and mitochondrial apoptosis induced by ROS generation-an in vitro and in vivo study

  2018cites this paper
• Biological aspects of chondrosarcoma: Leaps and hurdles.

  2018cites this paper
• Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance

  2018influential citation
• Cartilage diseases.

  2018cites this paper
• Clinical Benefit of Pazopanib in a Patient with Metastatic Chondrosarcoma: A Case Report and Review of the Literature

  2018cites this paper
• Pyrroloquinoline quinone induces chondrosarcoma cell apoptosis by increasing intracellular reactive oxygen species

  2018cites this paper
• Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets.

  2018cites this paper
• Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2018cites this paper
• Marital Status and Survival of Patients with Chondrosarcoma: A Population-Based Analysis

  2018cites this paper
• Biology of Bone Sarcomas and New Therapeutic Developments

  2017cites this paper
• Evidence-Based Treatment for Malignant Paediatric Bone Tumours

  2017cites this paper
• Description of the immune microenvironment of chondrosarcoma and contribution to progression

  2017cites this paper
• Identification of an easy to use 3D culture model to investigate invasion and anticancer drug response in chondrosarcomas

  2017cites this paper
• Bortezomib induces apoptosis and suppresses cell growth and metastasis by inactivation of Stat3 signaling in chondrosarcoma.

  2017cites this paper
• Novel therapeutic approaches in chondrosarcoma.

  2017cites this paper
• Knockdown of long non-coding RNA HOTAIR increases miR-454-3p by targeting Stat3 and Atg12 to inhibit chondrosarcoma growth

  2017cites this paper
• Endoscopic Endonasal Approach in Skull Base Chondrosarcoma Associated with Maffucci Syndrome: Case Series and Literature Review.

  2016cites this paper
• Inhibition of Autophagy Increases 2‐Methoxyestradiol‐Induced Cytotoxicity in SW1353 Chondrosarcoma Cells

  2016cites this paper
• Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ?

  2016cites this paper
• Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma

  2016cites this paper
• Diagnostics and treatment options in low-grade central chondrosarcomas

  2016cites this paper
• Screening and improving the safe provision of mesenchymal stem cells in regenerative medicine : an in vitro study

  2016cites this paper
• Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy

  2015cites this paper
• Tumors of bone

  2015cites this paper
• Bone cancer incidence by morphological subtype: a global assessment

  2015cites this paper
• Slug signaling is up-regulated by CCL21/CXCR7 to induce EMT in human chondrosarcoma

  2015cites this paper
• Chondrosarcoma of a rib

  2015cites this paper
• Chapter 1 – Epidemiology of primary bone tumors and economical aspects of bone metastases

  2015cites this paper
• Chondrosarcoma of the hyoid bone: a case report.

  2015cites this paper
• An orthotopic mouse model for chondrosarcoma of bone provides an in vivo tool for drug testing

  2015cites this paper
• Role of mesenchymal stem cells in bone cancer; initiation, propagation and metastasis

  2015cites this paper
• Biology of Central and Peripheral Chondrosarcoma

  2014cites this paper
• Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2014cites this paper
• Intracortical chondrosarcoma: a case report.

  2014cites this paper
• Chondrosarcoma of bone.

  2014cites this paper
• Chondrosarcoma of the chest wall: Single-center experience

  2014cites this paper
• Evaluating the Role of PTH in Promotion of Chondrosarcoma Cell Proliferation and Invasion by Inhibiting Primary Cilia Expression

  2014cites this paper
• Elevated Levels of Dickkopf-1 Are Associated with β-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma

  2014cites this paper
• Gallic acid induces apoptosis and inhibits cell migration by upregulating miR-518b in SW1353 human chondrosarcoma cells.

  2014cites this paper
• Histologic variants of chondrosarcoma

  2014cites this paper
• Bone sarcomas : ESMO Clinical Practice Guidelines for diagnosis , treatment and follow-up † The ESMO / European Sarcoma Network Working Group * incidence

  2014cites this paper